Top line decelerating.
+28.5% YoY versus +97.0% prior. 3y CAGR +137.0%.
+28.5%We use cookies
MainRatios uses cookies for essential site functions. With your consent, we also use analytics cookies including session replay sampling (PostHog, Google Analytics) and advertising cookies (Google AdSense). You can reject non-essential cookies, including the "sale" or sharing of personal information under CCPA, and you may withdraw consent at any time (GDPR). See our Privacy Policy for details.
Healthcare · Market Cap: $5.3B
Live price unavailable
Fundamentals as of 2026-03-31
All analysis on this page is for educational purposes only and does not constitute financial advice. Fair values are model-based estimates. Always do your own research.
Yes — Apellis Pharmaceuticals, Inc.'s 32.1% ROE ranks above the S&P 500 median, and D/E 1.61 stays within healthy bounds.
Financial story
Yes — Apellis Pharmaceuticals, Inc.'s 32.1% ROE shows strong capital efficiency, and its 1.61 debt-to-equity stays within healthy bounds.
Bottom line: APLS currently has no legendary investor models qualifying — see /stock/APLS/valuation for the per-model breakdown, but earns a C sector grade (48/100) in Healthcare. Use the per-tab analysis to form your own view. Drill into the valuation breakdown and sector ranking for the full picture.
The Question
How does APLS compare?
Investor verdicts for APLS are listed in the valuation tab. Per-model fair value and reasoning are in the valuation tab.
APLS's P/E ratio is 38.7x. 5-year P/E history is in the financials tab.
Investor verdicts vary by methodology. Full breakdown by investor and signal is in the valuation tab.
APLS's earnings calendar and history are tracked in the financials tab. Specific dates depend on company-published guidance.
APLS is in the Healthcare sector. Sector ranking and peer comparison are in the sector tab.
0 of 6 legendary investor models rate APLS a BUY. Fair value estimates and full investor breakdown are in the valuation tab.
See exactly where APLS ranks
Sign in to unlock the full sector ranking — free.
Sign in to see the rankingAPLS sits at #63 in Healthcare with a C grade (48/100).